Wood AJJ, ed
Cc tinh cht ny c tc dng lm trng sng, ngn nga lo ha v ci thin sc khe ln da
Yang N, Wang J, Liu C, Song Y, Zhang S, Zi J, et al

Key Points The incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived hormones that potentiate insulin secretion and contribute to glucose metabolism through a wide range of physiological actions Inhibitors of the incretin-inactivating enzyme dipeptidyl peptidase 4 (DPP-4) and DPP-4-resistant injectable GLP-1 receptor agonists have been developed for the treatment of hyperglycaemia in type 2 diabetes mellitus (T2DM) GLP-1 and other gut-derived hormones might directly and/or indirectly regulate electrolyte and fluid homeostasis by influencing feeding and drinking behaviour as well as electrolyte transport in the kidneys and gastrointestinal tract GLP-1 receptor (GLP-1R) agonists and DPP-4 inhibitors increase natriuresis in T2DM, possibly through overlapping and distinct mechanisms, and might slightly improve renal haemodynamics in the setting of diabetes-related glomerular hyperfiltration Incretin-based therapies seem to directly influence renal physiology and have indirect metabolic and haemodynamic actions that might reduce renal risk in T2DM

New research shows that eating animal products causes animal sugars, such as Neu5Gc, to become attached to cells that line our hollow organs, like the stomach, causing the body to make antibodies against these sugars resulting in chronic inflammation and, therefore, impaired B12 absorption
That is why you should not get the injection if you know you are allergic to glutathione